QS Investors’s Integra LifeSciences IART Stock Holding History

QS Investors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,300	Closed	-$62K	–	1341
2020 Q2	$62K	Hold	1,300	–	–	﹤0.01%	1421
2020 Q1	$59K	Hold	1,300	–	–	﹤0.01%	1380
2019 Q4	$76K	Hold	1,300	–	–	﹤0.01%	1430
2019 Q3	$79K	Hold	1,300	–	–	﹤0.01%	1432
2019 Q2	$73K	Hold	1,300	–	–	﹤0.01%	1449
2019 Q1	$73K	Sell	1,300 -8	-0.6%	-$407	﹤0.01%	1461
2018 Q4	$59K	Hold	1,308	–	–	﹤0.01%	1436
2018 Q3	$86K	Hold	1,308	–	–	﹤0.01%	1421
2018 Q2	$84K	Hold	1,308	–	–	﹤0.01%	1440
2018 Q1	$72K	Hold	1,308	–	–	﹤0.01%	1429
2017 Q4	$63K	Hold	1,308	–	–	﹤0.01%	1446
2017 Q3	$66K	Hold	1,308	–	–	﹤0.01%	1465
2017 Q2	$71K	Hold	1,308	–	–	﹤0.01%	1445
2017 Q1	$55K	Buy	1,308 +1,300	+16,250%	+$55.5K	﹤0.01%	1489
2016 Q4	$1K	Hold	8	–	–	﹤0.01%	1627
2016 Q3	$1K	Buy	8 +2	+33%	+$84	﹤0.01%	1611
2016 Q2	$1K	Buy	+6	New	+$216	﹤0.01%	1649
2016 Q1	–	Sell	-8	Closed	-$1K	–	2014
2015 Q4	$1K	Buy	+8	New	+$250	﹤0.01%	1670

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

QS Investors's IART Position: Q3 2020 in Review

QS Investors sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 1,300 shares — an estimated $62K sold.

QS Investors first reported a position in IART in Q4 2015 and held it in 18 quarters. The position peaked at $86K in Q3 2018. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

QS Investors reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
QS Investors sold 1,300 Integra LifeSciences shares in Q3 2020, an estimated $62K.
QS Investors first reported a position in Integra LifeSciences in Q4 2015 and held it in 18 quarters.
QS Investors's Integra LifeSciences position peaked at $86K in Q3 2018.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.